21.92
전일 마감가:
$21.91
열려 있는:
$22.84
하루 거래량:
154.68K
Relative Volume:
0.77
시가총액:
$409.30M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.19%
1개월 성능:
+10.65%
6개월 성능:
-47.03%
1년 성능:
+32.85%
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
TECX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TECX
Tectonic Therapeutic Inc
|
21.92 | 431.71M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-11 | 재개 | Raymond James | Outperform |
2025-04-21 | 개시 | Mizuho | Outperform |
2024-11-20 | 개시 | Raymond James | Outperform |
2024-08-22 | 개시 | Wells Fargo | Overweight |
2024-06-26 | 개시 | Piper Sandler | Overweight |
2024-06-24 | 개시 | TD Cowen | Buy |
2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-06-15 | 개시 | BTIG Research | Buy |
2021-05-27 | 개시 | Needham | Buy |
2021-03-09 | 개시 | Barclays | Overweight |
2021-03-02 | 개시 | Stifel | Hold |
2020-11-11 | 개시 | Berenberg | Buy |
2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2019-06-27 | 개시 | Mizuho | Buy |
2019-04-05 | 개시 | Janney | Buy |
2018-10-10 | 개시 | Guggenheim | Buy |
2018-10-02 | 재확인 | H.C. Wainwright | Buy |
2018-09-17 | 개시 | H.C. Wainwright | Buy |
2018-07-16 | 개시 | Wedbush | Outperform |
2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Is Tectonic Therapeutic Inc. a good long term investmentTremendous gains - Autocar Professional
Tectonic Therapeutic, Inc. Rings the Closing Bell - Nasdaq
Truist Securities initiates Tectonic Therapeutics stock with Buy rating - Investing.com India
Tectonic Therapeutic Inc. Stock Analysis and ForecastStrong return on assets - PrintWeekIndia
What drives Tectonic Therapeutic Inc. stock priceHigh-return market picks - PrintWeekIndia
What analysts say about Tectonic Therapeutic Inc. stockExplosive returns - jammulinksnews.com
What institutions are buying Tectonic Therapeutic Inc. stock nowFree Stock Market Analysis Courses - Newser
What analysts say about Tectonic Therapeutic Inc. stock outlookBreakout Level Watch - Newser
What makes Tectonic Therapeutic Inc. stock price move sharplyLow Risk Consistent Winners - Newser
How Tectonic Therapeutic Inc. stock performs during market volatilityLong Term Secure Gain Stocks - Newser
Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Russell 2000 Implied Analyst Target Price at $269.34, 20.67% Upside to Current Price of $223.21. - AInvest
Tectonic Therapeutic shares fall 1.44% intraday after filing $400 million mixed shelf. - AInvest
Tectonic Therapeutics: Strategic Capital Allocation Fuels Growth in Untapped GPCR Markets - AInvest
Tectonic Therapeutic Files $400 Million Mixed Shelf - MarketScreener
Clinical-Stage Biotech Tectonic Therapeutic Secures Coveted Russell 3000 Index Position - Stock Titan
Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating - MSN
13 Small Cap Stocks Analysts Are Bullish On - Insider Monkey
Tectonic Therapeutic (NASDAQ:TECX) & Invivyd (NASDAQ:IVVD) Head-To-Head Comparison - Defense World
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated at Raymond James - Defense World
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) PT at $80.50 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Upgraded at Lifesci Capital - Defense World
Lifesci Capital Initiates Coverage on Tectonic Therapeutic (NASDAQ:TECX) - Defense World
tectonic therapeutic holds annual meeting, elects directors By Investing.com - Investing.com India
LifeSci Capital Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Tectonic Therapeutic Holds 2025 Annual Stockholders Meeting - TipRanks
tectonic therapeutic holds annual meeting, elects directors - Investing.com
Ameriprise Financial Inc. Takes $347,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High? - MSN
Millennium Management LLC Invests $1.33 Million in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Northern Trust Corp Raises Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):